XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity/(Deficit) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balance at Dec. 31, 2022 $ (44,368) $ 0 $ 118,024 $ 1,661 $ (45,868) $ (161)
Beginning balance, shares at Dec. 31, 2022   875,279 33,336,282      
Stock-based compensation expense 533     533    
Net Income (Loss) (7,089)       (7,089)  
Other comprehensive income loss 104         104
Ending balance at Mar. 31, 2023 (50,820) $ 0 $ 118,024 2,194 (52,957) (57)
Ending balance, shares at Mar. 31, 2023   875,279 33,336,282      
Beginning balance at Dec. 31, 2022 (44,368) $ 0 $ 118,024 1,661 (45,868) (161)
Beginning balance, shares at Dec. 31, 2022   875,279 33,336,282      
Net Income (Loss) (18,229)          
Ending balance at Jun. 30, 2023 (61,460) $ 0 $ 118,024 2,656 (64,097) (19)
Ending balance, shares at Jun. 30, 2023   875,279 33,336,282      
Beginning balance at Mar. 31, 2023 (50,820) $ 0 $ 118,024 2,194 (52,957) (57)
Beginning balance, shares at Mar. 31, 2023   875,279 33,336,282      
Stock-based compensation expense 462     462    
Net Income (Loss) (11,140)       (11,140)  
Other comprehensive income loss 38         38
Ending balance at Jun. 30, 2023 (61,460) $ 0 $ 118,024 2,656 (64,097) (19)
Ending balance, shares at Jun. 30, 2023   875,279 33,336,282      
Beginning balance at Dec. 31, 2023 168,870 $ 15 $ 0 258,231 (89,423) 47
Beginning balance, shares at Dec. 31, 2023   14,817,696 0      
Issuance of common stock and pre-funded warrants in connection with the private placement, net of issuance costs 215,333 $ 14   215,319    
Issuance of common stock and pre-funded warrants in connection with the private placement, net of issuance costs, shares   14,500,500        
Exercise of stock options 271     271    
Exercise of stock options, shares   30,430        
Stock-based compensation expense 2,035     2,035    
Net Income (Loss) (13,748)       (13,748)  
Other comprehensive income loss (74)         (74)
Ending balance at Mar. 31, 2024 372,687 $ 29 $ 0 475,856 (103,171) (27)
Ending balance, shares at Mar. 31, 2024   29,348,626 0      
Beginning balance at Dec. 31, 2023 $ 168,870 $ 15 $ 0 258,231 (89,423) 47
Beginning balance, shares at Dec. 31, 2023   14,817,696 0      
Exercise of stock options, shares 33,944          
Net Income (Loss) $ (31,355)          
Ending balance at Jun. 30, 2024 358,218 $ 29 $ 0 479,004 (120,778) (37)
Ending balance, shares at Jun. 30, 2024   29,352,140 0      
Beginning balance at Mar. 31, 2024 372,687 $ 29 $ 0 475,856 (103,171) (27)
Beginning balance, shares at Mar. 31, 2024   29,348,626 0      
Exercise of stock options 47     47    
Exercise of stock options, shares   3,514        
Stock-based compensation expense 3,101     3,101    
Net Income (Loss) (17,607)       (17,607)  
Other comprehensive income loss (10)         (10)
Ending balance at Jun. 30, 2024 $ 358,218 $ 29 $ 0 $ 479,004 $ (120,778) $ (37)
Ending balance, shares at Jun. 30, 2024   29,352,140 0